Status | Study |
Not yet recruiting |
Study Name: The p53 Colorectal Cancer Trial Condition: Colorectal Cancer Metastatic Colorectal Cancer Stage IV Date: 2017-03-14 Interventions: Drug: Cyclophosphamide Chemotherapy Other Name: Send |
Recruiting |
Study Name: A Study Evaluating Venetoclax in Subjects With Chronic Lymphocytic Leukemia Whose Cancer Has Come Back or Who Had No Response to Previous Cancer Treatments Including Subjects Missing Part of Their Chromosome 17, or TP53 Gene Mutation; or Who Received Prior Treatment With a B-Cell Receptor Inhibitor Condition: Chronic Lymphocytic Leukemia (CLL) Date: 2016-11-30 Interventions: Drug: Venetoclax Tablet Other Name: ABT-199 |
Recruiting |
Study Name: Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes Condition: Li-Fraumeni Syndrome Date: 2016-10-11 Interventions: Device: Whole Body MRI |
Not yet recruiting |
Study Name: p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma Condition: HCC Diabetes Date: 2015-09-11 Interventions: Drug: p53 gene therapy Trans-c |
Recruiting |
Study Name: Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma Condition: Advanced Hepatocellular Carcinoma (HCC) Date: 2015-07-19 Interventions: Drug: TAE plus P53 gene Trans- |
Not yet recruiting |
Study Name: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condition: Ovarian Epithelial Cancer Fallopian Tube Cancer Primary Pe Date: 2015-04-28 Interventions: Drug: p53 gene p53 gene will b |
Not yet recruiting |
Study Name: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion Condition: Malignant Pleural Effusion Date: 2015-04-24 Interventions: Drug: rAdp53 Recombinant adeno |
Not yet recruiting |
Study Name: P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer Condition: Advanced Head and Neck Cancer Date: 2015-04-20 Interventions: Drug: rAd-p53 multi-point inje |
Recruiting |
Study Name: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma Condition: Advanced Adult Hepatocellular Carcinoma Date: 2015-03-25 Interventions: Drug: TACE plus rAd-p53 artery injection |
Active, not recruiting |
Study Name: Biomarker Monitoring in TP53 Mutation Carriers Condition: Li-Fraumeni Syndrome Hereditary Cancer Syndromes Date: 2014-11-10 |